7th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Disease, Poster Session, Oct. 14-17, 2001
A New Selective COX-2 Inhibitor: Morinda citrifolia (NONI)
Su, C.

In vitro study showed that TNJ is a selective COX-2 inhibitor. In comparison to aspirin, Indomethacin, and Celebrex?, the selective inhibition is comparable to Celebrex?, a well-known selective COX-2 inhibitor.